{
  "symbol": "ACRS",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Small-cap biotech sector",
      "Focus on novel drug candidates"
    ],
    "riskScore": 7,
    "reason": "Aclaris Therapeutics operates in the small-cap biotech sector, which is prone to retail speculation and social media hype due to its focus on novel drug candidates for immune-inflammatory diseases."
  }
}